- [Alveolo-interstitial pneumonia due to Temozolamide]L Guilleminault
Service de Pneumologie, CHU de Tours, Universite Francois Rabelais de Tours, France
Rev Mal Respir 25:880-4. 2008..Temozolomide is an alkylating agent approved for treatment of glioblastoma in association with radiotherapy...
- Can exhaled nitric oxide differentiate causes of pulmonary fibrosis?L Guilleminault
CHRU Tours, Service de Pneumologie et d explorations fonctionnelles respiratoires, Tours, France Université François Rabelais de Tours, CEPR, Inserm U1100 EA6305, Faculte de Medecine, Tours, France Electronic address
Respir Med 107:1789-96. 2013..The aim of the present study was to determine whether there are differences in FENO (fraction of exhaled nitric oxide) between different subtypes of fibrotic ILD...
- [Tropical pneumonia: pulmonary melioidosis]L Guilleminault
Service de Pneumologie, Hopital Bretonneau, CHRU de Tours, Universite Francois Rabelais, 2, boulevard Tonnelle, 37044 Tours cedex 9, France
Rev Med Interne 31:e4-7. 2010..No relapse had occurred 18 months later...
- Asthma unmasked with tumor necrosis factor-α-blocking drugsLaurent Guilleminault
Service de pneumologie et exploration fonctionnelle respiratoire, Hopital Bretonneau, Tours, France
Chest 140:1068-71. 2011..The pathophysiologic mechanisms are unknown but are probably more complex than the T helper 1/T helper 2 imbalance suggested in the literature, and further studies are required...
- An evaluation of a new single-use flexible bronchoscope with a large suction channel: reliability of bronchoalveolar lavage in ventilated piglets and initial clinical experienceJ Mankikian
CHRU de Tours, Service de Reanimation Polyvalente, Tours, France
Anaesthesia 69:701-6. 2014..This encouraging preliminary evaluation demonstrates the effectiveness of this new single-use device, which may obviate the need for disinfection procedures and, thereby, eradicate a potential vector of patient cross-contamination. ..
- Initial characteristics and outcome of hospitalized patients with amiodarone pulmonary toxicityJ Mankikian
CHRU Tours, Service de Pneumologie, Tours, France
Respir Med 108:638-46. 2014..Amiodarone-induced pulmonary toxicity (APT) is a serious adverse event that can lead to death. The aims of our study are to determine factors associated with mortality and to describe outcome and sequelae of patients with APT...